Correction: Externally controlled drug release using a gold nanorod contained composite membrane
Kibeom Kim1, Min-Chul Jo2, Sundo Jeong2
1Department of Chemistry, Sahmyook University, Seoul, 01795, Korea. mpark@syu.ac.kr and Department of Chemistry, Ulsan National Institute of Science and Technology, Ulsan, 44919, Korea. jhryu@unist.ac.kr.
Nanoscale
|November 2, 2016
Summary
This correction clarifies details regarding externally controlled drug release. The study involved a composite membrane containing gold nanorods for precise therapeutic delivery.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Composite membranes are crucial for controlled drug delivery systems.
- Gold nanorods offer unique optical properties for external control.
- Previous work explored their integration into drug release membranes.
Purpose of the Study:
- To correct inaccuracies in the original publication.
- To ensure precise understanding of the externally controlled drug release mechanism.
- To provide accurate data on the gold nanorod composite membrane.
Main Methods:
- Correction of experimental parameters and data presentation.
- Re-evaluation of the composite membrane fabrication process.
- Clarification of the externally controlled drug release mechanism using gold nanorods.
Main Results:
- Accurate representation of the composite membrane's properties.
- Corrected data on drug release profiles under external control.
- Verified performance of the gold nanorod-based system.
Conclusions:
- The corrected findings reinforce the potential of gold nanorod composite membranes for externally controlled drug release.
- Ensured accuracy in understanding the material's performance.
- Highlights the importance of precise reporting in nanotechnology applications.
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
66
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
66
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
73
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
73
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
111
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
111
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
76
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
76
01:23Modified-Release Drug Delivery Systems: Classification
162
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
162
01:11Oral Drug Delivery Systems: Delayed-Release Systems
91
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
91